Immunocore Holdings plc
IMCR
$37.88
$1.714.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.85% | 4.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.85% | 4.35% | |||
| Cost of Revenue | 1.48% | 8,329.36% | |||
| Gross Profit | 16.81% | -70.00% | |||
| SG&A Expenses | -7.04% | 6.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.75% | 15.74% | |||
| Operating Income | 51.79% | -311.37% | |||
| Income Before Tax | 103.14% | -259.34% | |||
| Income Tax Expenses | -20.63% | -42.88% | |||
| Earnings from Continuing Operations | 98.28% | -305.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 98.28% | -305.06% | |||
| EBIT | 51.79% | -311.37% | |||
| EBITDA | 54.79% | -410.32% | |||
| EPS Basic | 98.29% | -304.19% | |||
| Normalized Basic EPS | 103.15% | -1,664.94% | |||
| EPS Diluted | 98.29% | -304.80% | |||
| Normalized Diluted EPS | 103.15% | -1,728.38% | |||
| Average Basic Shares Outstanding | 0.22% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.22% | -3.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||